Filing Details
- Accession Number:
- 0001181431-12-067631
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2012-12-31 16:39:03
- Reporting Period:
- 2012-12-27
- Filing Date:
- 2012-12-31
- Accepted Time:
- 2012-12-31 16:39:03
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1400431 | Patheon Inc | PTI | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1518451 | Gordon Brian Shaw | 40 University Avenue Suite 1300 Toronto A6 M5P 2E9 | Yes | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Restricted Voting Shares | Acquisiton | 2012-12-27 | 15,000 | $3.40 | 93,000 | No | 4 | P | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Direct |
Footnotes
- The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $3.38 to $3.42, inclusive. The reporting person undertakes to provide to Patheon Inc., any security holder of Patheon Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth this footnote (1). The amounts reported in column 4 and this footnote (1) were converted from Canadian dollars into U.S. dollars based on the December 27, 2012 closing exchange rate of 0.995 Canadian dollars per U.S. dollar as quoted by Reuters.